← Human Trials & Peer-Reviewed Studies
Performing resistance exercise before versus after aerobic exercise influences growth hormone secretion in type 1 diabetes.
Plain-language guide to PMID 24476484 (2014): crossover randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 24476484
- Journal
- Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
- Year
- 2014
- Study type
- Randomized Controlled Trial
- Authors
- Yardley JE et al. (5 authors)
- DOI
- 10.1139/apnm-2013-0329
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The researchers compared growth hormone (GH) and plasma glucose (PG) levels in type 1 diabetic individuals performing aerobic before resistance exercise (AR) to when resistance exercise was performed first (RA).
In AR, GH secretion declined in late exercise while it rose throughout exercise in RA, resulting in higher GH in RA versus AR at exercise completion.
Who Took Part
The age groups tagged for this paper are adults, both men and women.
How the Study Was Run
The researchers set it up as a randomized and crossover study.
The participants were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.
In the crossover set-up each of the participants took both Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and the comparison in turn, acting as their own control.
What Was Measured
The researchers compared growth hormone (GH) and plasma glucose (PG) levels in type 1 diabetic individuals performing aerobic before resistance exercise (AR) to when resistance exercise was performed first (RA).
Topics PubMed links to this paper include Blood Glucose, Diabetes Mellitus, Type 1, Exercise and Human Growth Hormone.
What This Means in Plain Language
The paper is a randomized and crossover study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The publication is from 2014 (Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme), a journal based in Canada.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.